How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Multiple Sclerosis Treatment

ZINCARE

M. Chomba

TBC vs CBD in Rheumatoid Arthritis Patients: What Is The Latest Clin…

Daniel Arkfeld

ECTRIMS 2024 Insights: Real-World Evidence on Infection-Related Hosp…

Afagh Garjani

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

ECTRIMS 2024 Insights: Increased Brain Age Is Associated With Clinic…

Lonneke Bos

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Top Shoulder Problems You See in the Office

UCSF School of Medicine

B. Feeley

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush

Aberrant Iron Deposition in the Progressive MS Spinal Cord Relates t…

Marco Pisa

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush

Rheumatoid Arthritis: Update on Treatment Strategies

University of Colorado Department of Medicine

L. W. Moreland

USSONAR Rheumatology Ultrasound Case Series: Rheumatoid Arthritis an…

USSONAR

J. Yinh

COVID-19 & Multiple Sclerosis: Can Immunosuppressive Therapy Decreas…

Gavin Giovannoni

The Role of B Cells in Progressive MS and the Long-term Effects of B…

The France Foundation

J. Berger

Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20-Treat…

Dominika Stastna

Breaking Down Common But Complicated Questions in MS: Updates on Bio…

Women Neurologists Group (WNG)

E. M. Schorr

Paramagnetic Rim Lesions Predict Greater Long-Term Relapse Rates and…

Jack A. Reeves